Studies in mice reveal a role for anthrax toxin receptors in matrix metalloproteinase function and extracellular matrix homeostasis

Toxins

Volumn 5, Issue 2, 2013, Pages 315-326

  Reeves, Claire ^a   Charles Horvath, Pelisa ^a   Kitajewski, Jan ^a  

^a Department of Medicine   (United States)

Author keywords

Anthrax intoxication; Anthrax toxin receptors; Extracellular matrix homeostasis; MT1 MMP

Indexed keywords

ANTHRAX TOXIN; MATRIX METALLOPROTEINASE;

ANTHRAX TOXIN RECEPTOR GENE; ENZYME ACTIVITY; ENZYME BINDING; EXTRACELLULAR MATRIX; GENE DELETION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; HOMEOSTASIS; INTOXICATION; NONHUMAN; PHENOTYPE; PHYSIOLOGICAL PROCESS; PROTEIN FUNCTION; RECEPTOR GENE; REVIEW;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMANS; MATRIX METALLOPROTEINASES; MICE; NEOPLASMS; RECEPTORS, PEPTIDE; REPRODUCTION;

EID: 84873534881     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins5020315     Document Type: Review

References (41)

1. Bradley, K.A.; Mogridge, J.; Mourez, M.; Collier, R.J.; Young, J.A. Identification of the cellular receptor for anthrax toxin. Nature 2001, 414, 225-229.
2. Scobie, H.M.; Rainey, G.J.; Bradley, K.A.; Young, J.A. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 2003, 100, 5170-5174.
3. Young, J.A.; Collier, R.J. Anthrax toxin: Receptor binding, internalization, pore formation, and translocation. Annu. Rev. Biochem. 2007, 76, 243-265.
4. Van der Goot, G.; Young, J.A., Receptors of anthrax toxin and cell entry. Mol. Asp. Med. 2009, 30, 406-412.
5. Deuquet, J.; Lausch, E.; Superti-Furga, A.; van der Goot, F.G. The dark sides of capillary morphogenesis gene 2. EMBO J. 2012, 31, 3-13.
6. St Croix, B.; Rago, C.; Velculescu, V.; Traverso, G.; Romans, K.E.; Montgomery, E.; Lal, A.; Riggins, G.J.; Lengauer, C.; Vogelstein, B.; Kinzler, K.W. Genes expressed in human tumor endothelium. Science 2000, 289, 1197-1202.
7. Bell, S.E.; Mavila, A.; Salazar, R.; Bayless, K.J.; Kanagala, S.; Maxwell, S.A.; Davis, G.E. Differential gene expression during capillary morphogenesis in 3D collagen matrices: Regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J. Cell Sci. 2001, 114, 2755-2773.
8. Vargas, M.; Karamsetty, R.; Leppla, S.H.; Chaudry, G.J. Broad expression analysis of human ANTXR1/TEM8 transcripts reveals differential expression and novel Splizce variants. PLoS One 2012, 7, e43174.
9. Cryan, L.M.; Rogers, M.S., Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy. Front. Biosci. 2011, 16, 1574-1588.
10. Hotchkiss, K.A.; Basile, C.M.; Spring, S.C.; Bonuccelli, G.; Lisanti, M.P.; Terman, B.I., TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp. Cell Res. 2005, 305, 133-144.
11. Rmali, K.A.; Puntis, M.C.; Jiang, W.G. TEM-8 and tubule formation in endothelial cells, its potential role of its vW/TM domains. Biochem. Biophys. Res. Commun. 2005, 334, 231-238.
12. Reeves, C.V.; Dufraine, J.; Young, J.A.; Kitajewski, J. Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis. Oncogene 2010, 29, 789-801.
13. Nanda, A.; Carson-Walter, E.B.; Seaman, S.; Barber, T.D.; Stampfl, J.; Singh, S.; Vogelstein, B.; Kinzler, K.W.; St Croix, B. TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res. 2004, 64, 817-820.
14. Dowling, O.; Difeo, A.; Ramirez, M.C.; Tukel, T.; Narla, G.; Bonafe, L.; Kayserili, H.; Yuksel-Apak, M.; Paller, A.S.; Norton, K.; et al., Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am. J. Hum. Genet. 2003, 73, 957-966.
15. Werner, E.; Kowalczyk, A.P.; Faundez, V. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J. Biol. Chem. 2006, 281, 23227-23236.
16. Yang, M.Y.; Chaudhary, A.; Seaman, S.; Dunty, J.; Stevens, J.; Elzarrad, M.K.; Frankel, A.E.; St Croix, B. The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton. Biochim. Biophys. Acta 2011, 1813, 39-49.
17. Trescos, Y.; Tournier, J.N. Cytoskeleton as an emerging target of anthrax toxins. Toxins 2012, 4, 83-97.
18. Liu, S.; Crown, D.; Miller-Randolph, S.; Moayeri, M.; Wang, H.; Hu, H.; Morley, T.; Leppla, S.H. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc. Natl. Acad. Sci. USA 2009, 106, 12424-12429.
19. Cullen, M.; Seaman, S.; Chaudhary, A.; Yang, M.Y.; Hilton, M.B.; Logsdon, D.; Haines, D.C.; Tessarollo, L.; St Croix, B. Host-derived tumor endothelial marker 8 promotes the growth of melanoma. Cancer Res. 2009, 69, 6021-6026.
20. Chaudhary, A.; Hilton, M.B.; Seaman, S.; Haines, D.C.; Stevenson, S.; Lemotte, P.K.; Tschantz, W.R.; Zhang, X.M.; Saha, S.; Fleming, T.; St Croix, B. TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types. Cancer Cell 2012, 21, 212-226.
21. Chaudhary, A.; St Croix, B. Selective blockade of tumor angiogenesis. Cell Cycle 2012, 11, 2253-2259.
22. Bonuccelli, G.; Sotgia, F.; Frank, P.G.; Williams, T.M.; de Almeida, C.J.; Tanowitz, H.B.; Scherer, P.E.; Hotchkiss, K.A.; Terman, B.I.; Rollman, B.; et al. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: Implications for the pathogenesis of anthrax infection. Am. J. Physiol. 2005, 288, C1402-C1410.
23. Reeves, C.V.; Wang, X.; Charles-Horvath, P.C.; Vink, J.Y.; Borisenko, V.Y.; Young, J.A.; Kitajewski, J.K. Anthrax toxin receptor 2 functions in ECM homeostasis of the murine reproductive tract and promotes MMP activity. PLoS One 2012, 7, e34862.
24. Peters, D.E.; Zhang, Y.; Molinolo, A.A.; Miller-Randolph, S.; Szabo, R.; Bugge, T.H.; Leppla, S.H.; Liu, S. Capillary morphogenesis protein-2 is required for mouse parturition by maintaining uterine collagen homeostasis. Biochem. Biophys. Res. Commun. 2012, 422, 393-397.
25. Nagase, H.; Visse, R.; Murphy, G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 2006, 69, 562-573.
26. Strongin, A.Y.; Collier, I.; Bannikov, G.; Marmer, B.L.; Grant, G.A.; Goldberg, G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 1995, 270, 5331-5338.
27. Sato, H.; Takino, T.; Okada, Y.; Cao, J.; Shinagawa, A.; Yamamoto, E.; Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994, 370, 61-65.
28. Hernandez-Barrantes, S.; Toth, M.; Bernardo, M.M.; Yurkova, M.; Gervasi, D.C.; Raz, Y.; Sang, Q.A.; Fridman, R. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem. 2000, 275, 12080-12089.
29. Visse, R.; Nagase, H., Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ. Res. 2003, 92, 827-839.
30. Vartak, D.G.; Gemeinhart, R.A. Matrix metalloproteases: Underutilized targets for drug delivery. J. Drug Targ. 2007, 15, 1-20.
31. Butler, G.S.; Butler, M.J.; Atkinson, S.J.; Will, H.; Tamura, T.; Schade van Westrum, S.; Crabbe, T.; Clements, J.; d'Ortho, M.P.; Murphy, G. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A.kinetic study. J. Biol. Chem. 1998, 273, 871-880.
32. Atkinson, S.J.; Crabbe, T.; Cowell, S.; Ward, R.V.; Butler, M.J.; Sato, H.; Seiki, M.; Reynolds, J.J.; Murphy, G. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J. Biol. Chem. 1995, 270, 30479-30485.
33. Moayeri, M.; Leppla, S.H. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol. Asp. Med. 2009, 30, 439-455.
34. Bosshart, H.; Humphrey, J.; Deignan, E.; Davidson, J.; Drazba, J.; Yuan, L.; Oorschot, V.; Peters, P.J.; Bonifacino, J.S. The cytoplasmic domain mediates localization of furin to the trans-Golgi network en route to the endosomal/lysosomal system. J. Cell Biol. 1994, 126, 1157-1172.
35. Schafer, W.; Stroh, A.; Berghofer, S.; Seiler, J.; Vey, M.; Kruse, M.L.; Kern, H.F.; Klenk, H.D.; Garten, W. Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. EMBO J. 1995, 14, 2424-2435.
36. Liu, S.; Zhang, Y.; Hoover, B.; Leppla, S.H. The receptors that mediate the direct lethality of anthrax toxin. Toxins 2013, 5, 1-8.
37. Rozanov, D.V.; Golubkov, V.S.; Strongin, A.Y. Membrane type-1 matrix metalloproteinase (MT1-MMP) protects malignant cells from tumoricidal activity of re-engineered anthrax lethal toxin. Int. J. Biochem. Cell Biol. 2005, 37, 142-154.
38. Mayer, G.; Boileau, G.; Bendayan, M., Furin interacts with proMT1-MMP and integrin alphaV at specialized domains of renal cell plasma membrane. J. Cell Sci. 2003, 116, 1763-1773.
39. Rozanov, D.V.; Strongin, A.Y., Membrane type-1 matrix metalloproteinase functions as a proprotein self-convertase. Expression of the latent zymogen in Pichia pastoris, autolytic activation, and the peptide sequence of the cleavage forms. J. Biol. Chem. 2003, 278, 8257-8260.
40. Vuyisich, M.; Sanders, C.K.; Graves, S.W., Binding and cell intoxication studies of anthrax lethal toxin. Mol. Biol. Rep. 2012, 39, 5897-5903.
41. Martchenko, M.; Candille, S.I.; Tang, H.; Cohen, S.N. Human genetic variation altering anthrax toxin sensitivity. Proc. Natl. Acad. Sci. USA 2012, 109, 2972-2977.